DOI:
10.1055/s-00000045
Der Nuklearmediziner
LinksClose Window
References
Rathke H, Afshar-Oromieh A, Giesel FL. et al.
Intraindividual comparison of 99mTc-Methylene Diphosphonate and prostate-specific membrane antigen ligand 99mTc-MIP-1427 in patients with osseous metastasized prostate cancer.
Journal of Nuclear Medicine 2018;
59: 1373-1379
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.